(Q73510487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

W H Adler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P V Baskar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F J Chrest

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B Dorsey-Cooper

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R A Winchurch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J E Nagel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of Ageing and Development

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

137-155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Human immunodeficiency virus-1 disease progression in hemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Survival patterns of the first 500 patients with AIDS in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Survival trends for patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Development of AIDS in people with transfusion-acquired HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/microL.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Age as a prognostic factor in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

The effect of aging on susceptibility to infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Viral counts count in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Plasma viral load, CD4+ cell counts, and HIV-1 production by cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

HIV viral load markers in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

New concepts in the immunopathogenesis of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

1 reference

7 January 2021

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Susceptibility of human-mouse T cell hybrids to HIV-productive infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Human genes other than CD4 facilitate HIV-1 infection of murine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Activation of dual T cell signaling pathways by the chemokine RANTES

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

RANTES, MIP-1 alpha and MIP-1 beta are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

CD8+ T-cell-mediated suppression of HIV-1 infection may not be due to chemokines RANTES, MIP-1 alpha and MIP-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Chemokine production in HIV-seropositive long-term asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

RANTES, MIP and interleukin-16 in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

HIV suppression by interleukin-16.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

In vitro activation of T lymphocytes from HIV-seropositive blood donors. II. Decreased mitogen-induced expression of interleukin 2 receptor by both CD4 and CD8 cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Diminished interleukin 2 production and receptor generation characterize the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Changing the natural history of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Host factors and the pathogenesis of HIV-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Survival from early, intermediate, and late stages of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Site-directed serology of HIV-1 subtype B infection: relation between virus specific antibody levels and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

The immunopathogenesis of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Failure of T-cell homeostasis preceding AIDS in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Blind T-cell homeostasis in CD4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Tracking of markers and onset of disease among HIV-1 seroconverters

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Increases in soluble CD8 antigen in plasma, and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

1 reference

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Cytokine production pathway in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Th1 and Th2 subsets: paradigms lost?

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Immune-based therapeutics: scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Age as a predictor of progression in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901888-5

7 January 2021

10.1016/S0047-6374(97)01888-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9223117%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference